RUNX1 and acute myeloid leukemia: As we failed to produce high-quality results with commercially available antibodies against mouse RUNX1, we conducted RUNX1 ChIP-seq with the above-mentioned human THP-1 AML cells following induction of shRNAs against PU.1 or a scramble control.